Laurus Labs schedules Q2 FY27 earnings call for October 29

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Laurus Labs will hold its Q2 and H1 FY27 earnings conference call on October 29, 2026
  • The call is scheduled for 5:00 pm IST and hosted by DAM Capital Advisors
  • International dial-ins are available for investors in Singapore, Hong Kong, USA, and UK
  • The company reported ₹6,813 crore in annual revenue during FY26
powered bylight_fuzz_icon
53439146

*this image is generated using AI for illustrative purposes only.

Laurus Labs Limited will host a conference call on Thursday, October 29, 2026, at 5:00 pm IST to discuss its second quarter and first half FY27 financial results. The event includes an interactive Q&A session with management.

The call is organized in collaboration with DAM Capital Advisors. Investors and analysts can join via primary and secondary dial-in numbers provided in the official notice. International access is available through toll-free numbers in Singapore, Hong Kong, USA, and UK.

Call Logistics

Participants can access the earnings discussion using the following details:

Detail Information
Date October 29, 2026
Time 5:00 pm IST
Host DAM Capital Advisors
Primary Dial-in +91 22 6280 1384
Secondary Dial-in +91 22 7115 8285

International dial-in options include Singapore (+8001012045), Hong Kong (+800964448), USA (+18667462133), and UK (+08081011573). A Diamond Pass event link is also referenced for digital participation.

Company Profile

Laurus Labs is a research-driven pharmaceutical manufacturing organization specializing in APIs and intermediates. The company holds global leadership positions in anti-retroviral, oncology, cardiovascular, and gastro therapeutics. It operates as a Contract Development and Manufacturing Organization (CDMO) with facilities approved by global regulators including the USFDA, WHO, and EMA.

The company employs over 8,126 people, including more than 3,134 scientists, across 15 facilities. In FY26, Laurus Labs generated ₹6,813 crore in annual revenue.

Historical Stock Returns for Laurus Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%+3.11%+6.91%+84.33%+135.36%0.0%

How will Laurus Labs' Q2 FY27 performance compare to its FY26 revenue baseline of ₹6,813 crore?

What specific growth drivers in the CDMO segment are expected to influence the upcoming financial results?

How might recent regulatory inspections by the USFDA or EMA impact Laurus Labs' future capacity utilization?

Laurus Labs shares worth ₹61.44 crore flag large-trade signal on BSE

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Approximately 302,000 Laurus Labs shares flagged in a large-trade signal on BSE
  • Shares changed hands at ₹2034.30 per share, with a combined value of ₹61.44 crore
  • This is a real-time signal from trade-scanning activity, not a confirmed exchange-reported event
  • Buyer, seller, and client identity remain unknown until exchange disclosure after market close
powered bylight_fuzz_icon
52978535

*this image is generated using AI for illustrative purposes only.

Laurus Labs shares worth ₹61.44 crore changed hands on BSE in a large-trade signal, with approximately 302,000 shares transacting at a price of ₹2034.30 per share.

This is a real-time large-trade signal, not a confirmed block or bulk deal. NSE/BSE publish official block and bulk deal reports only after market close — this trade may or may not appear there.

Large-trade signal details

The following table summarises the key parameters of the flagged activity:

Parameter Details
Exchange BSE
Approximate quantity ~302,000 shares
Trade price ₹2034.30 per share
Approximate value ₹61.44 crore

The signal reflects a cluster of trades in Laurus Labs shares printed within a short window at or near ₹2034.30, flagged by the real-time trade-scanning system on account of size and speed. No buyer, seller, broker, or client identity is known at this stage, as such information is disclosed by the exchange only after market close.

What this signal is, and is not

What this is, and isn't: this reflects trade-level activity — a cluster of trades in the stock above, printed within a short window at or near the quoted price, for a combined value as stated. It is generated by our real-time trade-scanning system and is not, by itself, evidence of a block or bulk deal.

A block deal has to be executed in the exchange's dedicated window (8:45–9:00am or 2:05–2:20pm), within a set price band, and above the current minimum order size (₹25 crore). A bulk deal is when one client's total trading in a stock crosses 0.5% of its equity in a single day — confirmed only once every trade that client made is added up.

Both are published by NSE/BSE after trading hours end, typically after 3:30pm — never before. If this trade qualifies as either, it will appear in the exchange's own report later today, not here first.

Historical Stock Returns for Laurus Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%+3.11%+6.91%+84.33%+135.36%0.0%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

Will the exchange's post-market report confirm this activity as a formal block or bulk deal, and if so, who are the identified counterparties?

How does this ₹61.44 crore transaction volume compare to Laurus Labs' average daily turnover, and what does it suggest about institutional interest?

What recent developments in Laurus Labs' API or CDMO pipeline might explain a sudden surge in high-value trading activity?

More News on Laurus Labs

1 Year Returns:+135.36%